The predictive value of blood neutrophil-lymphocyte ratio in patients with end-stage liver cirrhosis following ABO-incompatible liver transplantation

Background: The study was designed to assess the role of preoperative neutrophil, lymphocyte, and neutrophil-lymphocyte ratio (NLR) in predicting survival outcomes of ABO-incompatible liver transplantation (LT). Materials and Methods: We retrospectively collected the demographic and clinical characteristics of 71 patients with end-stage liver cirrhosis following ABO-incompatible LT in this study. Kaplan–Meier survival analysis and Cox multiple factors regression analysis were performed to determine the independent risk factors from preoperative blood parameters for poor prognosis. Results: The 1-, 3-, and 5-year overall survival were 94.9%, 80.0%, and 80.0% in the normal NLR group, respectively, and 59.4%, 55,4%, and 55.4% in patients with up-regulated NLR, respectively (P = 0.001). Furthermore, no significant difference was observed on post-LT complications between normal NLR and high-NLR groups. The high NLR was identified as the only independent prognostic risk factor for recipient survival (P = 0.015, 95% confidence interval = 3.573 [1.284–9.943]). Conclusion: The preoperative high NLR could be considered as a convenient and available indicator for selecting ABO-incompatible LT candidates.

[1]  L. A. Szutan,et al.  Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients , 2015, Clinics.

[2]  Zhengwen Liu,et al.  Prognostic role of neutrophil‐to‐lymphocyte ratio in colorectal cancer: A systematic review and meta‐analysis , 2014, International journal of cancer.

[3]  G. Mody,et al.  Acute presentation of thrombocytopaenia in systemic lupus erythematosus is associated with a high mortality in South Africa , 2014, Lupus.

[4]  D. Altshuler,et al.  Peritransplant absolute lymphocyte count as a predictive factor for advanced recurrence of hepatitis C after liver transplantation , 2014, Hepatology.

[5]  M. Abouljoud,et al.  Peritransplant Lymphopenia Is a Novel Prognostic Factor in Recurrence of Hepatocellular Carcinoma After Liver Transplantation , 2013, Transplantation.

[6]  H. Kanemoto,et al.  Elevated Preoperative Neutrophil-to-lymphocyte Ratio as a Predictor of Survival After Gastroenterostomy in Patients with Advanced Pancreatic Adenocarcinoma , 2013, Annals of Surgical Oncology.

[7]  Y. Beyazit,et al.  Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity. , 2012, Clinics and research in hepatology and gastroenterology.

[8]  S. Yagi,et al.  Splenectomy Does Not Offer Immunological Benefits in ABO-Incompatible Liver Transplantation With a Preoperative Rituximab , 2012, Transplantation.

[9]  Guihua Chen,et al.  A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation , 2011, PloS one.

[10]  R. Golfieri,et al.  Analysis of Factors Affecting Recurrence of Hepatocellular Carcinoma After Liver Transplantation With a Special Focus on Inflammation Markers , 2011, Transplantation.

[11]  Y. Maehara,et al.  Rituximab, IVIG, and Plasma Exchange Without Graft Local Infusion Treatment: A New Protocol in ABO Incompatible Living Donor Liver Transplantation , 2009, Transplantation.

[12]  H. Ohdan,et al.  Current status of liver transplantation across ABO blood-type barrier. , 2008, Journal of hepato-biliary-pancreatic surgery.

[13]  Y. Maehara,et al.  Successful ABO incompatible living donor liver transplantation in a patient with high isoagglutinin titer using high-dose intravenous immunoglobulin. , 2007, Transplantation proceedings.

[14]  M. Tanabe,et al.  Present status of ABO‐incompatible living donor liver transplantation in Japan , 2007, Hepatology.

[15]  François Vincent,et al.  Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. , 2007, Chest.

[16]  L. Morelli,et al.  Treatment of antibody‐mediated rejection with high‐dose immunoglobulins in ABO‐incompatible liver transplant recipient , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[17]  P. Hellberg,et al.  Neutrophil-mediated post-ischemic tubular leakage in the rat kidney. , 1989, Kidney international.

[18]  I. Liou Management of end-stage liver disease. , 2014, The Medical clinics of North America.

[19]  V. Arroyo,et al.  Compensated cirrhosis: Natural history and prognostic factors , 1987, Hepatology.